Table 2 Baseline characteristics
Parameter | Placebo (n = 20) | ASC (n = 40) | P-value |
|---|---|---|---|
Age (years) | 65.3 ± 8.7 | 65.5 ± 9.7 | 0.94 |
Male gender | 20 (100) | 35 (87.5) | 0.02 |
BMI (kg/m2) | 30.0 ± 4.8 | 30.0 ± 4.1 | 0.92 |
Smoking | 0.19 | ||
Current | 3 (15) | 8 (20) | |
Previous | 16 (80) | 23 (57.5) | |
Never | 1 (5) | 9 (22.5) | |
Diabetes mellitus | 6 (30) | 16 (40) | 0.57 |
Hypertension | 12 (60) | 33 (82.5) | 0.06 |
Previous AMI | 10 (50) | 26 (65) | 0.26 |
Previous CABG | 20 (100) | 33 (82.5) | 0.08 |
Previous PCI | 15 (75) | 28 (70) | 0.69 |
LVEF (%) | 54 ± 8 | 52 ± 8 | 0.38 |